Shanghai Runda Medical Technology Co., Ltd.
SSE:603108.SS
17.32 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8,311.78 | 9,147.373 | 10,494.419 | 8,860.108 | 7,069.156 | 7,051.95 | 5,964.339 | 4,318.81 | 2,164.689 | 1,628.642 | 1,358.503 | 1,025.89 | 772.339 | 631.452 |
| Cost of Revenue
| 6,203.492 | 6,718.371 | 7,557.067 | 6,468.094 | 5,157.435 | 5,136.604 | 4,323.479 | 3,102.844 | 1,556.494 | 1,185.742 | 999.041 | 736.955 | 542.68 | 410.265 |
| Gross Profit
| 2,108.288 | 2,429.001 | 2,937.352 | 2,392.014 | 1,911.721 | 1,915.346 | 1,640.86 | 1,215.966 | 608.195 | 442.9 | 359.462 | 288.934 | 229.659 | 221.188 |
| Gross Profit Ratio
| 0.254 | 0.266 | 0.28 | 0.27 | 0.27 | 0.272 | 0.275 | 0.282 | 0.281 | 0.272 | 0.265 | 0.282 | 0.297 | 0.35 |
| Reseach & Development Expenses
| 116.156 | 147.14 | 146.219 | 122.71 | 87.105 | 59.466 | 44.308 | 34.334 | 24.779 | 17.759 | 14.275 | 10.475 | 12.816 | 0 |
| General & Administrative Expenses
| 129.161 | 490.008 | 107.284 | 102.627 | 78.364 | 79.463 | 92.832 | 65.813 | 42.479 | 26.315 | 26.987 | 19.603 | 15.429 | 51.282 |
| Selling & Marketing Expenses
| 335.972 | 421.34 | 1,036.71 | 845.437 | 641.59 | 601.183 | 440.761 | 371.693 | 205.265 | 156.114 | 127.817 | 100.504 | 80.387 | 87.745 |
| SG&A
| 465.133 | 1,510.885 | 1,143.995 | 948.065 | 719.954 | 680.645 | 533.593 | 437.506 | 247.744 | 182.43 | 154.804 | 120.108 | 95.817 | 139.027 |
| Other Expenses
| 1,172.939 | 113.783 | 343.015 | 301.036 | 233.087 | 249.145 | -5.641 | -1.937 | 6.678 | 7.794 | 7.487 | 4.397 | 8.339 | 2.876 |
| Operating Expenses
| 1,754.228 | 1,771.808 | 1,633.229 | 1,371.811 | 1,040.145 | 989.256 | 808.294 | 639.657 | 364.845 | 265.808 | 216.777 | 171.335 | 142.827 | 142.249 |
| Operating Income
| 354.06 | 646.803 | 1,438.782 | 1,151.027 | 1,002.313 | 1,052.786 | 577.738 | 380.636 | 173.543 | 119.626 | 95.896 | 87.955 | 73.078 | 71.18 |
| Operating Income Ratio
| 0.043 | 0.071 | 0.137 | 0.13 | 0.142 | 0.149 | 0.097 | 0.088 | 0.08 | 0.073 | 0.071 | 0.086 | 0.095 | 0.113 |
| Total Other Income Expenses Net
| -8.518 | 8.752 | 3.279 | -370.571 | -7.926 | -492.972 | 14.114 | 6.055 | -40.34 | 6.307 | 7.195 | 4.203 | 8.275 | 2.763 |
| Income Before Tax
| 345.542 | 655.555 | 819.651 | 780.456 | 635.836 | 685.693 | 591.852 | 386.691 | 179.649 | 125.933 | 103.09 | 92.158 | 81.353 | 73.943 |
| Income Before Tax Ratio
| 0.042 | 0.072 | 0.078 | 0.088 | 0.09 | 0.097 | 0.099 | 0.09 | 0.083 | 0.077 | 0.076 | 0.09 | 0.105 | 0.117 |
| Income Tax Expense
| 156.084 | 212.92 | 164.541 | 182.255 | 132.005 | 174.591 | 159.805 | 89.362 | 47.452 | 33.507 | 27.984 | 24.218 | 22.54 | 18.951 |
| Net Income
| 55.281 | 273.296 | 655.11 | 598.201 | 503.83 | 511.101 | 261.954 | 219.187 | 116.428 | 91.76 | 75.162 | 67.94 | 58.795 | 54.496 |
| Net Income Ratio
| 0.007 | 0.03 | 0.062 | 0.068 | 0.071 | 0.072 | 0.044 | 0.051 | 0.054 | 0.056 | 0.055 | 0.066 | 0.076 | 0.086 |
| EPS
| 0.09 | 0.47 | 1.13 | 1.03 | 0.87 | 0.88 | 0.45 | 0.38 | 0.23 | 0.2 | 0.2 | 0.18 | 0.15 | 0.15 |
| EPS Diluted
| 0.09 | 0.47 | 1.1 | 1.01 | 0.87 | 0.88 | 0.45 | 0.38 | 0.23 | 0.2 | 0.2 | 0.18 | 0.15 | 0.15 |
| EBITDA
| 1,052.705 | 1,364.616 | 1,521.758 | 1,328.351 | 1,182.489 | 1,153.643 | 988.389 | 649.848 | 334.733 | 231.331 | 178.349 | 132.931 | 101.305 | 81.384 |
| EBITDA Ratio
| 0.127 | 0.149 | 0.145 | 0.15 | 0.167 | 0.164 | 0.166 | 0.15 | 0.155 | 0.142 | 0.131 | 0.13 | 0.131 | 0.129 |